Quick Answer
GILEAD SCIENCES, INC. reported Diluted EPS of $6.78 per share for fiscal year 2025.
GILEAD SCIENCES, INC. Diluted EPS — Annual History
| Fiscal Year | Diluted EPS | YoY Change |
|---|---|---|
| 2025 | $6.78 | +1684.2% |
| 2024 | $0.38 | -91.6% |
| 2023 | $4.50 | +23.6% |
| 2022 | $3.64 | -26.2% |
| 2021 | $4.93 | +4830.0% |
| 2020 | $0.10 | -97.6% |
| 2019 | $4.22 | +1.2% |
| 2018 | $4.17 | +18.8% |
| 2017 | $3.51 | -64.7% |
| 2016 | $9.94 | -16.5% |
| 2015 | $11.91 | +62.0% |
| 2014 | $7.35 | +306.1% |
| 2013 | $1.81 | +10.4% |
| 2012 | $1.64 | -7.3% |
| 2011 | $1.77 | +6.6% |
| 2010 | $1.66 | -41.1% |
| 2009 | $2.82 | +36.9% |
| 2008 | $2.06 | +25.6% |
| 2007 | $1.64 | — |
Quarterly Diluted EPS
| Quarter Ending | Diluted EPS | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $2.43 | +143.0% | +55.8% |
| June 30, 2025 | $1.56 | +20.9% | +50.0% |
| March 31, 2025 | $1.04 | +131.1% | +4.0% |
| September 30, 2024 | $1.00 | -42.2% | -22.5% |
| June 30, 2024 | $1.29 | +55.4% | +138.6% |
| March 31, 2024 | -$3.34 | -517.5% | -293.1% |
| September 30, 2023 | $1.73 | +21.8% | +108.4% |
| June 30, 2023 | $0.83 | -8.8% | +3.7% |
- GILEAD SCIENCES, INC. showed an increase of +1684.2% in Diluted EPS compared to the prior fiscal year.
- Over the 2007–2025 period, GILEAD SCIENCES, INC.’s diluted eps has grown by 313.4% (from $1.64 per share to $6.78 per share).
- The most recent figure is from GILEAD SCIENCES, INC.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 24, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: